Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Drug Safety / Springer

Citation Profile [Updated: 2022-01-09 21:43:50]
5 Years H
5
Impact Factor
0.08
5 Years IF
0.07
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.09 0 0 0 0 0 0 0 0 0 0 0.04
1991 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1992 0 0.09 0 0 0 0 0 0 0 0 0 0 0.04
1993 0 0.11 0 0 0 0 0 0 0 0 0 0 0.05
1994 0 0.12 0 0 0 0 0 0 0 0 0 0 0.06
1995 0 0.19 0 0 0 0 0 0 0 0 0 0 0.08
1996 0 0.22 0 0 0 0 0 0 0 0 0 0 0.1
1997 0 0.22 0 0 0 0 0 0 0 0 0 0 0.09
1998 0 0.26 0 0 0 0 0 0 0 0 0 0 0.12
1999 0 0.27 0 0 0 0 0 0 0 0 0 0 0.13
2000 0 0.32 0 0 0 0 0 0 0 0 0 0 0.14
2001 0 0.35 0 0 0 0 0 0 0 0 0 0 0.15
2002 0 0.37 0 0 0 0 0 0 0 0 0 0 0.19
2003 0 0.4 0 0 0 0 0 0 0 0 0 0 0.19
2004 0 0.44 0 0 0 0 0 0 0 0 0 0 0.2
2005 0 0.45 0 0 0 0 0 0 0 0 0 0 0.21
2006 0 0.46 0 0 0 0 0 0 0 0 0 0 0.2
2007 0 0.42 0 0 0 0 0 0 0 0 0 0 0.18
2008 0 0.44 0 0 0 0 0 0 0 0 0 0 0.2
2009 0 0.43 0 0 0 0 0 0 0 0 0 0 0.21
2010 0 0.43 0 0 0 0 0 0 0 0 0 0 0.18
2011 0 0.45 0 0 0 0 0 0 0 0 0 0 0.2
2012 0 0.45 0 0 7 7 0 0 0 0 0 0 0.19
2013 0 0.5 0 0 0 7 0 0 7 7 0 0 0.21
2014 0 0.51 0 0 8 15 11 0 7 7 0 0 0.2
2015 0 0.5 0 0 1 16 0 0 8 15 0 0 0.19
2016 0.22 0.5 0.1 0.13 109 125 76 13 13 9 2 16 2 12 92.3 11 0.1 0.18
2017 0.15 0.5 0.14 0.17 119 244 56 35 48 110 17 125 21 30 85.7 9 0.08 0.18
2018 0.13 0.54 0.16 0.13 134 378 52 60 108 228 30 237 31 53 88.3 21 0.16 0.21
2019 0.09 0.58 0.14 0.08 131 509 30 72 180 253 22 371 30 63 87.5 24 0.18 0.21
2020 0.08 0.75 0.1 0.07 130 639 12 62 242 265 21 494 36 45 72.6 3 0.02 0.29
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12016Good Signal Detection Practices: Evidence from IMI PROTECT. (2016). Candore, Gianmario ; Slattery, Jim ; Bate, Andrew ; Bousquet, Cedric ; MacIa-Martinez, Miguel A ; Manlik, Katrin ; Seabroke, Suzie ; Noren, Niklas G ; Brueckner, Andreas ; Kayser, Michael ; Juhlin, Kristina ; Holle, Lionel ; Antoni, ; Tregunno, Phil ; Thakrar, Bharat ; Quarcoo, Naashika ; Southworth, Harry . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0405-1.

Full description at Econpapers || Download Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art. (2014). Callahan, Alison ; Low, Yen ; Tamang, Suzanne ; Finlayson, Sam ; Harpaz, Rave ; LePendu, Paea ; Shah, Nigam ; Jung, Kenneth ; Odgers, David . In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:777-790.

Full description at Econpapers || Download paper

7
32017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark ; Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

6
42016The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Rolfes, Lean ; Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0.

Full description at Econpapers || Download paper

6
52017Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®. (2017). Caster, Ola ; Fransson, Jonas ; Noren, Niklas G ; Chandler, Rebecca E ; Juhlin, Kristina ; Edwards, Ralph I. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0456-3.

Full description at Econpapers || Download paper

5
62016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Edwards, Ralph I ; Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

5
72018Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Watson, Sarah ; Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

5
82016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Sarker, Abeed ; Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

5
92016Sequence Symmetry Analysis as a Signal Detection Tool for Potential Heart Failure Adverse Events in an Administrative Claims Database. (2016). Wahab, Izyan A ; Pratt, Nicole L ; Roughead, Elizabeth E ; Ellett, Lisa Kalisch . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0391-8.

Full description at Econpapers || Download paper

5
102019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). , Antoni ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia ; Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Antoni, ; Vries, Sieta T. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®. (2016). Ampadu, Haggar H ; Sartori, Daniele ; Olsson, Sten ; Pal, Shanthi N ; Hoekman, Jarno ; Alexander, ; Bruin, Marieke L. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0387-4.

Full description at Econpapers || Download paper

4
122017Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). Vries, Sieta T ; PEter, ; Ruiz, Carmen Lasheras ; Houez, Franois ; Sutcliffe, Alastair ; Wong, Lisa . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x.

Full description at Econpapers || Download paper

4
132016Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Harmark, Linda ; Matos, Cristiano ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

4
142018Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Duong, Mai ; Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7.

Full description at Econpapers || Download paper

4
152018Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. (2018). Caster, Ola ; Stekelenborg, John ; Wisniewski, Antoni ; Vroman, Benoit ; Tcherny-Lessenot, Stephanie ; Noren, Niklas G ; Maskell, Simon ; Lerch, Magnus ; Kurzinger, Marie-Laure ; Dietrich, Juergen. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0699-2.

Full description at Econpapers || Download The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Benattia, Isma ; Smith, Meredith Y. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

4
172018Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Comfort, Shaun ; Fine, Jennifer ; Ramakrishnan, Cartic ; Nagarajan, Meenakshi ; Meireis, Shawman ; Dorrell, Darren ; Hudson, Zoe ; Perera, Sujan. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7.

Full description at Econpapers || Download paper

4
182014Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum. (2014). Lindquist, Marie ; Bate, Andrew ; Tuccori, Marco ; Hartigan-Go, Kenneth ; Beckmann, Jurgen ; McEwen, John ; Moride, Yola ; Wong, Ian ; Hagemann, Ulrich ; Boyd, Ian ; Olsson, Sten ; Edwards, I. ; Pal, Shanthi ; Pan, Gerald Dal ; Soulaymani-Bencheikh, Rachida ; Vaca, Claudia ; Bahri, Priya. In: Drug Safety. RePEc:spr:drugsa:v:37:y:2014:i:10:p:743-759.

Full description at Econpapers || Download paper

3
192017An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System. (2017). Iyer, Geetha ; Singh, Sonal ; Segal, Jodi B ; Marimuthu, Sathiya Priya . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:9:d:10.1007_s40264-017-0550-1.

Full description at Econpapers || Download paper

3
202016Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention. (2016). Brosch, Sabine ; Newbould, Victoria ; Goedecke, Thomas ; Ord, Kathryn ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0410-4.

Full description at Econpapers || Download paper

3
212016Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors. (2016). Chalmers, Leanne ; Curtain, Colin M ; Angamo, Mulugeta Tarekegn . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0444-7.

Full description at Econpapers || Download paper

3
222016Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A ; Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6.

Full description at Econpapers || Download paper<

3
232018Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab. (2018). Smith, Karen ; Gonzalez-Hernandez, Graciela ; Oconnor, Karen ; Loke, Yoon ; Sarker, Abeed ; Golder, SU. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0707-6.

Full description at Econpapers || Download paper

3
242016Clinicians’ Reports in Electronic Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin. (2016). Seger, Diane L ; Lai, Kenneth ; Topaz, Maxim ; Rozenblum, Ronen ; Dhopeshwarkar, Neil ; Zhou, LI ; Goss, Foster ; Saadon, Roee . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0381-x.

Full description at Econpapers || Download paper

3
252018From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Trifiro, Gianluca ; Bate, Andrew ; Sultana, Janet. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4.

Full description at Econpapers || Download paper

3
262017Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Luo, Yuan ; Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6.

Full description at Econpapers || Download paper

3
272019Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning. (2019). Popko, Leszek ; Bowling, Rich ; Koneswarakantha, Bjorn ; Barmaz, Yves ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00831-4.

Full description at Econpapers || Download paper

3
282018What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects. (2018). van Eekeren, Rike ; Harmark, Linda ; van Puijenbroek, Eugene ; Tanaka, Daisuke ; Schutte, Tim ; al Ramimmy, Hussain ; Parthasarathi, Gurumurthy ; Magro, Lara ; Koster, Andries S ; Rolfes, Lean . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0681-z.

Full description at Econpapers || Download Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. (2019). Ptaszyska-Neophytou, Alicia ; Maskell, Simon ; Powell, Gregory ; Ellenius, Johan ; Pierce, Carrie E ; Stekelenborg, John ; Brosch, Sabine ; Newbould, Victoria ; Lewis, David ; Pirmohamed, Munir ; Gama, Sara ; Noren, Niklas G ; Dietrich, Juergen ; Tregunno, Phil ; Dasgupta, Nabarun ; Caster, Ola ; Antoni, ; Bergvall, Tomas. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00858-7.

Full description at Econpapers || Download Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases. (2016). Painter, Jeffery ; Slattery, Jim ; Noren, Niklas G ; Arani, Ramin ; Wisniewski, Antoni ; Quarcoo, Naashika ; Juhlin, Kristina ; Candore, Gianmario ; Seabroke, Suzie ; Tregunno, Philip . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:4:d:10.1007_s40264-015-0388-3.

Full description at Econpapers || Download paper

3
312016National ADR Monitoring System in China. (2016). Wu, Guizhi ; Ye, Xiaofei ; Hou, Yongfang ; Li, Xinling . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0446-5.

Full description at Econpapers || Download paper

3
322017Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review. (2017). Alshehri, Ghadah H ; Ashcroft, Darren M ; Keers, Richard N. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:10:d:10.1007_s40264-017-0557-7.

Full description at Econpapers || Download paper

3
332019Drug-Induced Liver Injury: Highlights of the Recent Literature. (2019). Real, Mark ; Lewis, James H ; Rosenberg, Jessica ; Higley, Cory ; Barnhill, Michele S. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0743-2.

Full description at Econpapers || Download paper

2
342016An Integrative Data Science Pipeline to Identify Novel Drug Interactions that Prolong the QT Interval. (2016). Woosley, Raymond L ; Kass, Robert S ; Sampson, Kevin J ; Lorberbaum, Tal ; Tatonetti, Nicholas P. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-016-0393-1.

Full description at Econpapers || Download paper

2
3520192
362020Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clin. (2020). de Climens, Aude Roborel ; Nguyen-Pascal, My-Lien ; Burrows, Kate ; Brun-Strang, Catherine ; Findley, Amy ; Reaney, Matthew ; Gater, Adam. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00877-4.

Full description at Econpapers || Download

2
372018Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study. (2018). Landsberg, Wally ; Rahman, Mirza ; Heumen, Emiel ; Peters-Strickland, Timothy ; Geis, Uli ; Coppin-Renz, Antonia ; Al-Dakkak, Imad. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:8:d:10.1007_s40264-018-0662-2.

Full description at Econpapers || Download paper

2
382018Comment on “Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project”. (2018). Bousquet, Cedric ; Louet, Agnes Lillo-Le ; Bellet, Florelle ; Audeh, Bissan. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0747-y.

Full description at Econpapers || Download paper

2
392018Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs. (2018). Cheng, Ning ; Hansen, Richard A ; Page, David C ; Berg, Richard L ; Peissig, Peggy L ; Qian, Jingjing ; Alatawi, Yasser ; Motiur, MD. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:4:d:10.1007_s40264-017-0624-0.

Full description at Econpapers || Download paper

2
402016Traceability of Biologics in The Netherlands: An Analysis of Information-Recording Systems in Clinical Practice and Spontaneous ADR Reports. (2016). Klein, Kevin ; Puijenbroek, Eugene P ; Broekmans, Andre W ; Stolk, Pieter ; Bruin, Marie L ; Vermeer, Niels S. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:2:d:10.1007_s40264-015-0383-8.

Full description at Econpapers || Download paper

2
412019Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study. (2019). Denig, Petra ; Tregunno, Phil ; Ragunathan, Gowthamei ; Radecka, Anna ; Ptaszynska-Neophytou, Alicia ; Revelle, Patrick ; Harrison, Judy ; de Vries, Sieta T ; PEter, . In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:7:d:10.1007_s40264-019-00800-x.

Full description at Econpapers || Download paper

2
4220192
432016A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals. (2016). Grampp, Gustavo ; Felix, Thomas ; Brown, Carrie A ; Stergiopoulos, Stella ; Getz, Kenneth A. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0455-4.

Full description at Econpapers || Download paper

2
442020Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3.

Full description at Econpapers || Download paper

2
452016Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies. (2016). Raschi, Emanuel ; de Ponti, Fabrizio ; Ageno, Walter ; Bianchin, Matteo . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:12:d:10.1007_s40264-016-0464-3.

Full description at Econpapers || Download paper

2
462016Drug Interactions of Direct-Acting Oral Anticoagulants. (2016). Fitzgerald, John Leonard ; Howes, Laurence Guy . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0443-8.

Full description at Econpapers || Download paper

2
472019Pharmacoepidemiologic Evaluation of Birth Defects from Health-Related Postings in Social Media During Pregnancy. (2019). Golder, SU ; Gonzalez-Hernandez, Graciela ; Scarazzini, Linda J ; Bhattacharya, Mondira ; Malin, Murray ; Bland, Martin ; Oconnor, Karen ; Klein, Ari ; Weissenbacher, Davy ; Chiuve, Stephanie. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0731-6.

Full description at Econpapers || Download paper

2
482017Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications. (2017). Weinstein, Rachel B ; Fife, Daniel ; Patel, Kayur ; Swerdel, Joel ; Schuemie, Martijn ; Matcho, Amy ; Berlin, Jesse A ; Ryan, Patrick. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0581-7.

Full description at Econpapers || Download paper

2
492018Correction to: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence. (2018). Saucier, Roxanne ; Dasgupta, Nabarun ; Wolfe, Daniel. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0685-8.

Full description at Econpapers || Download paper

2
502019Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem. (2019). Campbell, Eric G ; Sinha, Michael S ; Kesselheim, Aaron S ; Dal, Gerald J ; Avorn, Jerry ; Zhou, Esther H ; Lappin, Brian M ; Rausch, Paula ; Schneeweiss, Sebastian. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00849-8.

Full description at Econpapers || Download paper

2
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12016Good Signal Detection Practices: Evidence from IMI PROTECT. (2016). Candore, Gianmario ; Slattery, Jim ; Bate, Andrew ; Bousquet, Cedric ; MacIa-Martinez, Miguel A ; Manlik, Katrin ; Seabroke, Suzie ; Noren, Niklas G ; Brueckner, Andreas ; Kayser, Michael ; Juhlin, Kristina ; Holle, Lionel ; Antoni, ; Tregunno, Phil ; Thakrar, Bharat ; Quarcoo, Naashika ; Southworth, Harry . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0405-1.

Full description at Econpapers || Download Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre. (2018). Watson, Sarah ; Hunsel, Florence ; Star, Kristina ; Zekarias, Alem ; Grundmark, Birgitta ; Harmark, Linda ; Taavola, Henric ; Chandler, Rebecca E. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0594-2.

Full description at Econpapers || Download paper

4
32019Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR. (2019). , Antoni ; Pierce, Carrie E ; Dasgupta, Nabarun ; Newbould, Victoria ; Ptaszynska-Neophytou, Alicia ; Eemeren, Raphael ; Maskell, Simon ; Lewis, David J ; Tregunno, Phil ; PEter, ; Harmark, Linda ; Gama, Sara ; Bodin-Parssinen, Stephanie ; Antoni, ; Vries, Sieta T. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-019-00813-6.

Full description at Econpapers || Download The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization. (2016). Benattia, Isma ; Smith, Meredith Y. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:9:d:10.1007_s40264-016-0426-9.

Full description at Econpapers || Download paper

3
52018Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media. (2018). Comfort, Shaun ; Fine, Jennifer ; Ramakrishnan, Cartic ; Nagarajan, Meenakshi ; Meireis, Shawman ; Dorrell, Darren ; Hudson, Zoe ; Perera, Sujan. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0641-7.

Full description at Econpapers || Download paper

3
62018From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources. (2018). Trifiro, Gianluca ; Bate, Andrew ; Sultana, Janet. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4.

Full description at Econpapers || Download paper

3
72018Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample. (2018). Duong, Mai ; Moore, Nicholas ; Blin, Patrick ; Droz, Cecile ; Lassalle, Regis ; Abouelfath, Abdelilah. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0686-7.

Full description at Econpapers || Download paper

3
82018What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects. (2018). van Eekeren, Rike ; Harmark, Linda ; van Puijenbroek, Eugene ; Tanaka, Daisuke ; Schutte, Tim ; al Ramimmy, Hussain ; Parthasarathi, Gurumurthy ; Magro, Lara ; Koster, Andries S ; Rolfes, Lean . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0681-z.

Full description at Econpapers || Download The Impact of Experiencing Adverse Drug Reactions on the Patient’s Quality of Life: A Retrospective Cross-Sectional Study in the Netherlands. (2016). Rolfes, Lean ; Puijenbroek, Eugene ; Taxis, Katja ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:8:d:10.1007_s40264-016-0422-0.

Full description at Econpapers || Download paper

3
102019Enabling Data-Driven Clinical Quality Assurance: Predicting Adverse Event Reporting in Clinical Trials Using Machine Learning. (2019). Popko, Leszek ; Bowling, Rich ; Koneswarakantha, Bjorn ; Barmaz, Yves ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:9:d:10.1007_s40264-019-00831-4.

Full description at Econpapers || Download paper

3
112017Frequency and Nature of Medication Errors and Adverse Drug Events in Mental Health Hospitals: a Systematic Review. (2017). Alshehri, Ghadah H ; Ashcroft, Darren M ; Keers, Richard N. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:10:d:10.1007_s40264-017-0557-7.

Full description at Econpapers || Download paper

3
122017Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. (2017). Pierce, Carrie E ; Dasgupta, Nabarun ; Edwards, Ralph I ; Walderhaug, Mark ; Brownstein, John S ; Freifeld, Clark C ; Le, Hoa ; Rodriguez, Harold W ; Proestel, Scott ; Pamer, Carol ; Bouri, Khaled. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0491-0.

Full description at Econpapers || Download paper

3
1320192
142017Patient Reporting in the EU: Analysis of EudraVigilance Data. (2017). Banovac, Marin ; Arlett, Peter ; Genov, Georgy ; Haerry, David ; Houez, Francois ; Slattery, Jim ; Candore, Gianmario . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0534-1.

Full description at Econpapers || Download paper

2
152018Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study. (2018). Landsberg, Wally ; Rahman, Mirza ; Heumen, Emiel ; Peters-Strickland, Timothy ; Geis, Uli ; Coppin-Renz, Antonia ; Al-Dakkak, Imad. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:8:d:10.1007_s40264-018-0662-2.

Full description at Econpapers || Download paper

2
162019Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem. (2019). Campbell, Eric G ; Sinha, Michael S ; Kesselheim, Aaron S ; Dal, Gerald J ; Avorn, Jerry ; Zhou, Esther H ; Lappin, Brian M ; Rausch, Paula ; Schneeweiss, Sebastian. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:11:d:10.1007_s40264-019-00849-8.

Full description at Econpapers || Download paper

2
172018Deaths from Medicines: A Systematic Analysis of Coroners’ Reports to Prevent Future Deaths. (2018). Ferner, Robin E ; Cox, Anthony R ; Easton, Craig. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:1:d:10.1007_s40264-017-0588-0.

Full description at Econpapers || Download paper

2
182017The Quality of Clinical Information in Adverse Drug Reaction Reports by Patients and Healthcare Professionals: A Retrospective Comparative Analysis. (2017). Rolfes, Lean ; Puijenbroek, Eugene ; Taxis, Katja ; Linden, Laura ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0530-5.

Full description at Econpapers || Download paper

2
192018Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study. (2018). Oosterhuis, Ingrid ; Harmark, Linda ; Caster, Ola ; Newbould, Victoria ; Gama, Sara ; Mas, Petar ; Tregunno, Philip M ; Taavola, Henric. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0679-6.

Full description at Econpapers || Download paper

2
202016Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter. (2016). Sarker, Abeed ; Gonzalez, Graciela ; Malone, Dan ; Smith, Karen ; Scotch, Matthew ; Ginn, Rachel ; Oconnor, Karen . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0379-4.

Full description at Econpapers || Download paper

2
212019Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance. (2019). Dal, Gerald J ; Wu, Eileen ; Muoz, Monica A ; Kortepeter, Cindy M ; Kalra, Dipti ; Harinstein, Lisa. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-0759-7.

Full description at Econpapers || Download paper

2
222016Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase®. (2016). Pariente, Antoine ; Salvo, Francesco ; Begaud, Bernard ; Arnaud, Mickael ; Montastruc, Franois. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:7:d:10.1007_s40264-016-0413-1.

Full description at Econpapers || Download paper

2
232016Social Media Listening for Routine Post-Marketing Safety Surveillance. (2016). Menius, Alan J ; Freifeld, Clark C ; Blowers, James ; Reblin, Tjark ; Seifert, Harry A ; Thomas, Michele ; Burstein, Phil J ; Powell, Gregory E ; Brownstein, John S ; Painter, Jeffery L ; Dasgupta, Nabarun ; Rodriguez, Harold W ; Pierce, Carrie E ; Bell, Heidi G. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:5:d:10.1007_s40264-015-0385-6.

Full description at Econpapers || Download paper<

2
242020Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clin. (2020). de Climens, Aude Roborel ; Nguyen-Pascal, My-Lien ; Burrows, Kate ; Brun-Strang, Catherine ; Findley, Amy ; Reaney, Matthew ; Gater, Adam. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00877-4.

Full description at Econpapers || Download

2
252017Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention. (2017). Brandenburg, Nancy A ; Zeldis, Jerome B ; Sheehan, Paul ; Houn, Florence ; Freeman, John ; Bwire, Robert. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-016-0501-2.

Full description at Econpapers || Download paper

2
262019Recommendations for the Use of Social Media in Pharmacovigilance: Lessons from IMI WEB-RADR. (2019). Ptaszyska-Neophytou, Alicia ; Maskell, Simon ; Powell, Gregory ; Ellenius, Johan ; Pierce, Carrie E ; Stekelenborg, John ; Brosch, Sabine ; Newbould, Victoria ; Lewis, David ; Pirmohamed, Munir ; Gama, Sara ; Noren, Niklas G ; Dietrich, Juergen ; Tregunno, Phil ; Dasgupta, Nabarun ; Caster, Ola ; Antoni, ; Bergvall, Tomas. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00858-7.

Full description at Econpapers || Download Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities’ Views and Needs. (2016). Harmark, Linda ; Matos, Cristiano ; Hunsel, Florence. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:11:d:10.1007_s40264-016-0453-6.

Full description at Econpapers || Download paper

2
282018Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab. (2018). Smith, Karen ; Gonzalez-Hernandez, Graciela ; Oconnor, Karen ; Loke, Yoon ; Sarker, Abeed ; Golder, SU. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0707-6.

Full description at Econpapers || Download paper

2
292019Artificial Intelligence and the Future of the Drug Safety Professional. (2019). Danysz, Karolina ; Desai, Sameen ; Widdowson, Mark ; Abatemarco, Danielle ; Mockute, Ruta ; Tetarenko, Niki ; Assuncao, Bruno ; Mingle, Edward ; Cicirello, Salvatore. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:4:d:10.1007_s40264-018-0746-z.

Full description at Econpapers || Download paper

2
3020192
312016Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?. (2016). Edwards, Ralph I ; Leufkens, Hubert ; Kant, Agnes ; Raine, June ; Harmark, Linda ; Moretti, Ugo ; Sarinic, Viola Macolic . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:10:d:10.1007_s40264-016-0441-x.

Full description at Econpapers || Download paper

2
322017Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study. (2017). Vries, Sieta T ; PEter, ; Ruiz, Carmen Lasheras ; Houez, Franois ; Sutcliffe, Alastair ; Wong, Lisa . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:5:d:10.1007_s40264-016-0494-x.

Full description at Econpapers || Download paper

2
332016Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error Prevention. (2016). Brosch, Sabine ; Newbould, Victoria ; Goedecke, Thomas ; Ord, Kathryn ; Arlett, Peter. In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:6:d:10.1007_s40264-016-0410-4.

Full description at Econpapers || Download paper

2
342018Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project. (2018). Caster, Ola ; Stekelenborg, John ; Wisniewski, Antoni ; Vroman, Benoit ; Tcherny-Lessenot, Stephanie ; Noren, Niklas G ; Maskell, Simon ; Lerch, Magnus ; Kurzinger, Marie-Laure ; Dietrich, Juergen. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0699-2.

Full description at Econpapers || Download Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature. (2017). Lofstedt, Ragnar ; Bouder, Frederic ; Way, Dominic ; Blazsin, Hortense . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:1:d:10.1007_s40264-016-0466-1.

Full description at Econpapers || Download paper

2
3620192
372020Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3.

Full description at Econpapers || Download paper

2
382016Clinicians’ Reports in Electronic Health Records Versus Patients’ Concerns in Social Media: A Pilot Study of Adverse Drug Reactions of Aspirin and Atorvastatin. (2016). Seger, Diane L ; Lai, Kenneth ; Topaz, Maxim ; Rozenblum, Ronen ; Dhopeshwarkar, Neil ; Zhou, LI ; Goss, Foster ; Saadon, Roee . In: Drug Safety. RePEc:spr:drugsa:v:39:y:2016:i:3:d:10.1007_s40264-015-0381-x.

Full description at Econpapers || Download paper

2
392017Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review. (2017). Luo, Yuan ; Starren, Justin ; Carson, Matthew B ; Jonnalagadda, Siddhartha R ; Berendsen, Mark A ; Zeng, Zexian ; Herr, Timothy M ; Thompson, William K. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:11:d:10.1007_s40264-017-0558-6.

Full description at Econpapers || Download paper

2
402019Drug-Induced Liver Injury: Highlights of the Recent Literature. (2019). Real, Mark ; Lewis, James H ; Rosenberg, Jessica ; Higley, Cory ; Barnhill, Michele S. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:3:d:10.1007_s40264-018-0743-2.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 21
YearTitle
2020Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project. (2020). Audeh, Bissan ; Bousquet, Cedric ; Louet, Agnes Lillo-Le ; Beyens, Marie-Noelle ; Bellet, Florelle. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:9:d:10.1007_s40264-020-00951-2.

Full description at Econpapers || Download paper

2020Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013. (2020). Tilyard, Murray W ; Reith, David M ; Tomlin, Andrew M ; Fountain, John S. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00885-4.

Full description at Econpapers || Download paper

2020Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands. (2020). Harmark, Linda ; van Hunsel, Florence ; Noren, Niklas G ; Santoro, Federica ; Meijer, Rietje ; Weits, Gerda. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:8:d:10.1007_s40264-020-00932-5.

Full description at Econpapers || Download paper

2020Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review. (2020). Russell, Andrea M ; Smith, Meredith Y ; Lovett, Rebecca M ; Morrato, Elaine H. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00905-8.

Full description at Econpapers || Download paper

2020The Portuguese generic medicines market: What’s next?. (2020). Julio, Rui Miranda ; de Matos, Andreia ; Ferreira, Diogo Cunha ; Nunes, Alexandre Morais. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:4:p:397-403.

Full description at Econpapers || Download paper

2020Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance. (2020). Moride, Yola ; Castilloux, Anne-Marie ; Sergerie, Martin ; Bergamasco, Aurore ; Kaplan, Sigal. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:2:d:10.1007_s40264-019-00882-7.

Full description at Econpapers || Download paper

2020Access to Chagas disease treatment in the United States after the regulatory approval of benznidazole. (2020). Reich, Michael R ; Maguire, James H ; Manne-Goehler, Jennifer ; Yoshioka, Kota. In: PLOS Neglected Tropical Diseases. RePEc:plo:pntd00:0008398.

Full description at Econpapers || Download paper

2020Chloroquine for COVID-19 Infection. (2020). Moore, Nicholas. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00933-4.

Full description at Econpapers || Download paper

2020Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update. (2020). Moore, Nicholas. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:4:d:10.1007_s40264-019-00900-8.

Full description at Econpapers || Download paper

2020Supply Analysis of Supplementary Products in Poland. (2020). Koziarska, Anna ; Hys, Katarzyna. In: European Research Studies Journal. RePEc:ers:journl:v:xxiii:y:2020:i:special1:p:549-571.

Full description at Econpapers || Download paper

2020An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System. (2020). Marwitz, Kathryn ; Muoz, Monica A ; Dal, Gerald J ; Kortepeter, Cindy M ; Jones, Christopher S. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00908-5.

Full description at Econpapers || Download paper

2020Communication issues contributing to medication incidents: Mixed‐method analysis of hospitals’ incident reports using indicator phrases based on literature. (2020). Syyrila, Tiina ; Harkanen, Marja ; Vehvilainenjulkunen, Katri. In: Journal of Clinical Nursing. RePEc:wly:jocnur:v:29:y:2020:i:13-14:p:2466-2481.

Full description at Econpapers || Download paper

2020Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands. (2020). , Peter ; PEter, ; Hugtenburg, Jacqueline G ; Vries, Sieta T ; Denig, Petra. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:7:d:10.1007_s40264-020-00922-7.

Full description at Econpapers || Download paper

2020Does Ibuprofen Worsen COVID-19?. (2020). Droz, Cecile ; Bosco-Levy, Pauline ; Blin, Patrick ; Carleton, Bruce ; Moore, Nicholas. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:7:d:10.1007_s40264-020-00953-0.

Full description at Econpapers || Download paper

2020Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand. (2020). Harmark, Linda ; Dong, Christine Yang ; Sheridan, Jane L ; Barnes, Joanne ; Harrison-Woolrych, Mira ; Vohra, Sunita. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00963-y.

Full description at Econpapers || Download paper

2020Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?. (2020). Bowling, Rich ; Popko, Leszek ; Barmaz, Yves ; Rolo, Donato ; Koneswarakantha, Bjorn ; Menard, Timothe. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:3:d:10.1007_s40264-019-00894-3.

Full description at Econpapers || Download paper

2020Healthcare students knowledge, attitude and perception of pharmacovigilance: A systematic review. (2020). al Aloola, Noha A ; Alwhaibi, Monira. In: PLOS ONE. RePEc:plo:pone00:0233393.

Full description at Econpapers || Download paper

2020Community Pharmacists’ Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand. (2020). Butler, Rachael ; Barnes, Joanne. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00980-x.

Full description at Econpapers || Download paper

2020Healthcare Database Networks for Drug Regulatory Policies: International Workshop on the Canadian, US and Spanish Experience and Future Steps for Italy. (2020). Suissa, Samy ; Milozzi, Federica ; Menniti-Ippolito, Francesca ; Gil, Miguel ; Brown, Jeffrey S ; Addis, Antonio ; Trotta, Francesco ; Sultana, Janet ; Trifiro, Gianluca. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:1:d:10.1007_s40264-019-00871-w.

Full description at Econpapers || Download paper

2020Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project. (2020). Gattepaille, Lucie M ; Ellenius, Johan ; Pierce, Carrie E ; Bergvall, Tomas ; Vidlin, Sara Hedfors. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:8:d:10.1007_s40264-020-00942-3.

Full description at Econpapers || Download paper

2020Pharmaceutical Benefit–Risk Perception and Age Differences in the USA and Germany. (2020). Lofstedt, Ragnar E ; Evensen, Darrick. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:11:d:10.1007_s40264-020-00977-6.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2020
YearCiting document
2020Evaluation of a Web-Based, ‘Purchase Event’ Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand. (2020). Harmark, Linda ; Dong, Christine Yang ; Sheridan, Jane L ; Barnes, Joanne ; Harrison-Woolrych, Mira ; Vohra, Sunita. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:10:d:10.1007_s40264-020-00963-y.

Full description at Econpapers || Download paper

2020An Evaluation of Postmarketing Reports with an Outcome of Death in the US FDA Adverse Event Reporting System. (2020). Marwitz, Kathryn ; Muoz, Monica A ; Dal, Gerald J ; Kortepeter, Cindy M ; Jones, Christopher S. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:5:d:10.1007_s40264-020-00908-5.

Full description at Econpapers || Download paper

2020Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment. (2020). Osborne, Vicki ; Shakir, Saad ; Roy, Debabrata ; Dhanda, Sandeep ; Denyer, Jacqueline ; Evans, Alison ; Lane, Samantha ; Davies, Miranda. In: Drug Safety. RePEc:spr:drugsa:v:43:y:2020:i:8:d:10.1007_s40264-020-00966-9.

Full description at Econpapers || Download paper

Recent citations received in 2019
YearCiting document
2019The Impact of Litigation-Associated Reports on Signal Identification in the US FDA’s Adverse Event Reporting System. (2019). Dal, Gerald J ; Muoz, Monica A. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:10:d:10.1007_s40264-019-00834-1.

Full description at Econpapers || Download paper

2019Authors’ Reply to Ravi Jandhyala’s Comment on “Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulator. (2019). Plueschke, Kelly ; Olmo, Carla Alonso ; McGettigan, Patricia ; PEter, ; Kurz, Xavier ; Bahri, Priya ; Zondag, Daniel ; Castillon, Mireia. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:12:d:10.1007_s40264-019-00863-w.

Full description at Econpapers || Download Safety of Novel Targeted Therapies in Oncology. (2019). Curigliano, Giuseppe ; Shah, Rashmi R. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:2:d:10.1007_s40264-018-0770-z.

Full description at Econpapers || Download paper

2019From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data. (2019). Koutkias, Vassilis. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:5:d:10.1007_s40264-018-00793-z.

Full description at Econpapers || Download paper

2019Frailty and Drug Safety at Older Ages. (2019). Gulliford, Martin . In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:6:d:10.1007_s40264-019-00796-4.

Full description at Econpapers || Download paper

2019A Profile of Adverse Drug Reactions of Atazanavir- and Lopinavir-Based Antiretroviral Regimens in Namibia. (2019). Adenuga, Babafunso Aderemi ; Rennie, Timothy William. In: Drug Safety. RePEc:spr:drugsa:v:42:y:2019:i:7:d:10.1007_s40264-019-00832-3.

Full description at Econpapers || Download paper

Recent citations received in 2018
YearCiting document
2018Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”. (2018). Silverman, Bernard ; Akerman, Sarah ; Sullivan, Maria ; Fratantonio, James ; Silveira, Alexandra ; Marcopul, Kimberley ; Jain, Priya ; Bloomgren, Gary. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0691-x.

Full description at Econpapers || Download paper

2018Authors’ Response to Silverman and Colleagues’ Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”. (2018). Dasgupta, Nabarun ; Wolfe, Daniel ; Saucier, Roxanne. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0692-9.

Full description at Econpapers || Download paper

2018Potential Risk Window for Opioid Overdose Related to Treatment with Extended-Release Injectable Naltrexone. (2018). Binswanger, Ingrid A ; Glanz, Jason M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:10:d:10.1007_s40264-018-0705-8.

Full description at Econpapers || Download paper

2018Reply to Ward and Colleagues’ Comment on “Using Human Experiments of Nature to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”. (2018). Jerome, Rebecca N ; Denny, Joshua C ; Lancaster, William J ; Ekstrom, Leeland ; Bernard, Gordon ; Bastarache, Lisa A ; Shirey-Rice, Jana K ; Roden, Dan M ; Pulley, Jill M. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0701-z.

Full description at Econpapers || Download paper

2018Ibuprofen and Paracetamol: Acceptably Safe for All?. (2018). Pigazzani, Filippo ; MacDonald, Thomas M ; MacKenzie, Isla. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:11:d:10.1007_s40264-018-0717-4.

Full description at Econpapers || Download paper

2018Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action. (2018). Raine, June ; Radecka, Anna ; Ivanovic, Jelena ; Pallos, Julia ; Montero, Dolores ; Straus, Sabine ; Lesicar, Marina ; Giusti, Marina Dimov ; Sarinic, Viola Macolic ; de Ferraz, Margarida Viana ; Foy, Mick ; Loughlin, Louise. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0708-5.

Full description at Econpapers || Download paper

2018Authors’ Response to Braillon’s Comment on: “Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring”. (2018). Simoons, Mirjam ; Ruhe, Henricus ; Bakker, Roberto ; Roon, Eric ; Mulder, Hans ; Seldenrijk, Adrie. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0716-5.

Full description at Econpapers || Download paper

2018Comment on: “Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs”. (2018). Suggs, Courtney M ; zhao, liang ; Swain, Richard S ; Mosholder, Andrew D ; Levin, Robert L. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0726-3.

Full description at Econpapers || Download paper

2018Authors Reply to Courtney Suggs and Colleagues’ Comment on: “Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs”. (2018). Hansen, Richard A ; Page, David C ; Berg, Richard L ; Peissig, Peggy L ; Qian, Jingjing ; Alatawi, Yasser ; Motiur, MD ; Cheng, Ning. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0728-1.

Full description at Econpapers || Download pape

2018Comment on “Central Demyelinating Diseases After Vaccination Against Hepatitis B Virus: A Disproportionality Analysis Within the VAERS Database”. (2018). Cohen, Carine ; Khromava, Alena ; Houdeau, Annick. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0733-4.

Full description at Econpapers || Download paper

2018Authors’ Reply to Katsuhiro Toda’s Comment on “Proton Pump Inhibitor Use and Risk of Developing Alzheimer’s Disease or Vascular Dementia: A Case-Control Analysis”. (2018). Imfeld, Patrick ; Meier, Christoph R ; Jick, Susan S ; Bodmer, Michael. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0741-4.

Full description at Econpapers || Download paper

2018Comment on “Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project”. (2018). Bousquet, Cedric ; Louet, Agnes Lillo-Le ; Bellet, Florelle ; Audeh, Bissan. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:12:d:10.1007_s40264-018-0747-y.

Full description at Econpapers || Download paper

2018Authors’ reply: Safety of Human Papillomavirus Vaccines. (2018). MacArtney, Kristine ; Brotherton, Julia ; Pillsbury, Alexis ; Patel, Cyra ; Phillips, Anastasia. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:5:d:10.1007_s40264-018-0655-1.

Full description at Econpapers || Download paper

2018Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population”. (2018). Kawada, Tomoyuki . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0670-2.

Full description at Econpapers || Download paper

2018Authors’ Reply to: Tomoyuki Kawada’s Comment on: “All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a . (2018). Peckham, Alyssa M ; Sclar, David A ; Fairman, Kathleen A. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:6:d:10.1007_s40264-018-0671-1.

Full description at Econpapers || Download paper

2018Active Safety Surveillance in Africa: Pragmatism and Agility. (2018). Alexander, . In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:8:d:10.1007_s40264-018-0677-8.

Full description at Econpapers || Download paper

2018Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis. (2018). Maura, Geric ; Pariente, Antoine ; Neumann, Anke ; Weill, Alain ; Coste, Joel ; Billionnet, Cecile. In: Drug Safety. RePEc:spr:drugsa:v:41:y:2018:i:9:d:10.1007_s40264-018-0668-9.

Full description at Econpapers || Download paper

Recent citations received in 2017
YearCiting document
2017Commercial Online Social Network Data and Statin Side-Effect Surveillance: A Pilot Observational Study of Aggregate Mentions on Facebook. (2017). Huesch, Marco D. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0577-3.

Full description at Econpapers || Download paper

2017Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?. (2017). Chandler, Rebecca E. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0593-3.

Full description at Econpapers || Download paper

2017Is Ribavirin Teratogenic in Humans? No Evidence So Far. (2017). Soriano, Vicente ; Barreiro, Pablo. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:12:d:10.1007_s40264-017-0597-z.

Full description at Econpapers || Download paper

2017Authors’ Reply to Jouanjus and Colleagues’ Comment on “Social Media Mining for Toxicovigilance: Automatic Monitoring of Prescription Medication Abuse from Twitter”. (2017). Sarker, Abeed ; Malone, Dan ; Gonzalez, Graciela . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:2:d:10.1007_s40264-016-0498-6.

Full description at Econpapers || Download paper

2017Authors’ Reply to Alain Braillon’s Comment on “Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing pr. (2017). Auffret, Marine ; Rolland, Benjamin ; Gautier, Sophie ; Bordet, Regis ; Cottencin, Olivier ; Deheul, Sylvie ; Duhamel, Alain ; Labreuche, Julien . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:4:d:10.1007_s40264-017-0513-6.

Full description at Econpapers || Download Medicines Save, Medicines Kill. (2017). Lexchin, Joel . In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:6:d:10.1007_s40264-017-0521-6.

Full description at Econpapers || Download paper

2017The Power of the Case Narrative - Can it be Brought to Bear on Duplicate Detection?. (2017). Noren, Niklas G. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:7:d:10.1007_s40264-017-0548-8.

Full description at Econpapers || Download paper

2017Good Intentions, But What About Unintended Consequences?. (2017). Kales, Helen C ; Maust, Donovan T. In: Drug Safety. RePEc:spr:drugsa:v:40:y:2017:i:8:d:10.1007_s40264-017-0554-x.

Full description at Econpapers || Download paper